Stilla Technologies has launched Naica, a digital polymerase chain reaction (PCR) system that features six fluorescent channels. Naica was introduced at the American Society of Human Genetics virtual meeting.
The Naica system supports cell and gene therapy research, cancer and liquid biopsy studies, the detection of infectious diseases in wastewater and food, and environmental testing, Stilla said.
At the meeting, Stilla and researchers from Saga Diagnostics in Lund, Sweden, presented a 24-plex digital PCR assay generated on the Naica system, according to the firm.
"From quantifying circulating tumor cells and cell-free DNA in liquid biopsies for oncology, to detecting low-level genetic variants in infectious diseases, multiplex digital PCR is allowing researchers to parse complex genomics data to gain real-world, clinical insights at both the patient and the population level," Rémi Dangla, PhD, co-founder and chief technology officer at Stilla, said in a statement.